Comparative In vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens
- PMID: 11083657
- PMCID: PMC90222
- DOI: 10.1128/AAC.44.12.3447-3450.2000
Comparative In vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens
Abstract
The in vitro activity of daptomycin against 224 current gram-positive clinical isolates including vancomycin-resistant Enterococcus faecium (VREF), methicillin-resistant Staphylococcus aureus (MRSA), methicillin-resistant Staphylococcus spp. (MRSS), and penicillin-resistant Streptococcus pneumoniae (PRSP) was evaluated. The MICs at which 90% of isolates are inhibited for daptomycin and vancomycin, respectively, were as follows: MRSA, 1 and 2 microg/ml; MRSS, 1 and 4 microg/ml; PRSP, 1 and 0.5 microg/ml; and VREF, 2 and >64 microg/ml. Daptomycin was bactericidal against 82% of 17 VREF isolates. The antibacterial activity of daptomycin was strongly dependent on the calcium concentration of the medium. Daptomycin was active against all gram-positive cocci tested.
Figures
References
-
- Benson C A, Beaudette F, Trenholm G. Comparative in vitro activity of LY146032, a new peptide, with vancomycin and eight other agents against gram-positive organisms. J Antimicrob Chemother. 1987;20:191–196. - PubMed
-
- Hanberger H, Nilsson L E, Maller R, Isaksson B. Pharmacodynamics of daptomycin and vancomycin on E. faecalis and S. aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs. Antimicrob Agents Chemother. 1991;35:1710–1716. - PMC - PubMed
-
- Lakey J H, Ptak M. Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY 146032 and phospholipid membranes. Biochemistry. 1988;27:4639–4645. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
